zanamivir has been researched along with Sensitivity and Specificity in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 10 (76.92) | 29.6817 |
| 2010's | 3 (23.08) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abed, Y; Boivin, G; Carbonneau, J; Kaiser, L; L'Huillier, AG | 1 |
| Balish, A; Bright, RA; Deyde, VM; Gubareva, LV; Klimov, AI; Lindstrom, S; Nguyen, T; Shu, B | 1 |
| Gu, Y; Kamiya, H; Komiya, N; Matsui, T; Okabe, N; Yahata, Y; Yasui, Y | 1 |
| Heikkinen, T; Heinonen, S; Lehtinen, P; Silvennoinen, H; Vainionpää, R | 1 |
| Cen, S; He, Z; Li, XY; Liu, ZL; Wang, X; Wang, Z; Wei, XL; Yin, X; Zhang, ZZ; Zhou, JM | 1 |
| Clements, DA; Hamilton, JD; Huber, J; Lee, PY; Matchar, DB; Peterson, ED | 1 |
| Drinka, PJ; Krause, P; Nest, L | 1 |
| Bellantonio, S; Rose, DN; Rothberg, MB | 1 |
| Baughman, TM; Hutton, KA; Wright, WL | 1 |
| Bethell, RC; Buxton, RC; Edwards, B; Juo, RR; Tisdale, M; Voyta, JC | 1 |
| Cross, J; Wedekind, CA | 1 |
13 other study(ies) available for zanamivir and Sensitivity and Specificity
| Article | Year |
|---|---|
Droplet digital PCR to investigate quasi-species at codons 119 and 275 of the A(H1N1)pdm09 neuraminidase during zanamivir and oseltamivir therapies.
Topics: Antiviral Agents; Codon; Drug Resistance, Viral; Genetic Variation; Genotyping Techniques; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Microbial Sensitivity Tests; Middle Aged; Mutation, Missense; Neuraminidase; Oseltamivir; Polymerase Chain Reaction; Sensitivity and Specificity; Zanamivir | 2017 |
Detection of molecular markers of antiviral resistance in influenza A (H5N1) viruses using a pyrosequencing method.
Topics: Amantadine; Animals; Antiviral Agents; Birds; Drug Resistance, Viral; Genetic Markers; Humans; Influenza A Virus, H5N1 Subtype; Influenza in Birds; Influenza, Human; Neuraminidase; Oseltamivir; Reverse Transcriptase Polymerase Chain Reaction; Rimantadine; RNA, Viral; Sensitivity and Specificity; Sequence Analysis, RNA; Zanamivir | 2009 |
Clinical features of cases of influenza A (H1N1)v in Osaka prefecture, Japan, May 2009.
Topics: Adolescent; Adult; Antigens, Viral; Antiviral Agents; Child; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Japan; Male; Middle Aged; Oseltamivir; Reagent Kits, Diagnostic; Reverse Transcriptase Polymerase Chain Reaction; Schools; Sensitivity and Specificity; Treatment Outcome; Young Adult; Zanamivir | 2009 |
Feasibility of diagnosing influenza within 24 hours of symptom onset in children 1-3 years of age.
Topics: Antigens, Viral; Antiviral Agents; Child, Preschool; Early Diagnosis; Feasibility Studies; Fluoroimmunoassay; Humans; Infant; Influenza A virus; Influenza B virus; Influenza, Human; Oseltamivir; Point-of-Care Systems; Polymerase Chain Reaction; Reagent Kits, Diagnostic; Sensitivity and Specificity; Zanamivir | 2011 |
[Establishment of drug screening assay and pharmacodynamic evaluation method targeting influenza RNA polymerase].
Topics: Alphainfluenzavirus; Amantadine; Antiviral Agents; Drug Evaluation, Preclinical; Genes, Reporter; HEK293 Cells; Humans; Luciferases; Oseltamivir; Plasmids; Reproducibility of Results; Ribavirin; RNA-Dependent RNA Polymerase; Sensitivity and Specificity; Transfection; Zanamivir | 2012 |
Economic analysis of influenza vaccination and antiviral treatment for healthy working adults.
Topics: Acetamides; Adolescent; Adult; Antiviral Agents; Computer Simulation; Cost of Illness; Cost-Benefit Analysis; Decision Trees; Drug Costs; Guanidines; Humans; Influenza Vaccines; Influenza, Human; Middle Aged; Oseltamivir; Pyrans; Rimantadine; Sensitivity and Specificity; Sialic Acids; Vaccination; Zanamivir | 2002 |
Clinical features of influenza a virus infection in older hospitalized persons.
Topics: Aged; Antiviral Agents; Guanidines; Humans; Influenza A virus; Influenza, Human; Inpatients; Pyrans; Sensitivity and Specificity; Sialic Acids; Zanamivir | 2003 |
Management of influenza in adults older than 65 years of age: cost-effectiveness of rapid testing and antiviral therapy.
Topics: Acetamides; Aged; Amantadine; Antiviral Agents; Computer Simulation; Cost-Benefit Analysis; Decision Support Techniques; Guanidines; Humans; Influenza, Human; Oseltamivir; Pyrans; Quality-Adjusted Life Years; Rimantadine; Sensitivity and Specificity; Sialic Acids; Zanamivir | 2003 |
Summaries for patients. Cost-effective management of flu in adults older than 65 years of age.
Topics: Acetamides; Aged; Amantadine; Antiviral Agents; Computer Simulation; Cost-Benefit Analysis; Decision Support Techniques; Guanidines; Humans; Influenza, Human; Oseltamivir; Pyrans; Quality-Adjusted Life Years; Rimantadine; Sensitivity and Specificity; Sialic Acids; Zanamivir | 2003 |
Determination of zanamivir in rat and monkey plasma by positive ion hydrophilic interaction chromatography (HILIC)/tandem mass spectrometry.
Topics: Animals; Antiviral Agents; Chromatography, Liquid; Enzyme Inhibitors; Haplorhini; Rats; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry; Zanamivir | 2007 |
Development of a sensitive chemiluminescent neuraminidase assay for the determination of influenza virus susceptibility to zanamivir.
Topics: Adamantane; Antiviral Agents; Enzyme Inhibitors; Guanidines; Luminescent Measurements; Microbial Sensitivity Tests; Neuraminidase; Orthomyxoviridae; Pyrans; Sensitivity and Specificity; Sialic Acids; Spectrometry, Fluorescence; Sugar Acids; Zanamivir | 2000 |
Guidance on the use of the anti-influenza drug, zanamivir.
Topics: Adult; Enzyme Inhibitors; Female; Guanidines; Guidelines as Topic; Humans; Influenza, Human; Male; Pyrans; Sensitivity and Specificity; Sialic Acids; Treatment Outcome; United Kingdom; Zanamivir | 2000 |
Advances in pharmacology. New treatments for influenza: neuraminidase inhibitors.
Topics: Acetamides; Antiviral Agents; Drug Approval; Guanidines; Humans; Influenza, Human; Neuraminidase; Oseltamivir; Pyrans; Sensitivity and Specificity; Sialic Acids; United States; Zanamivir | 2001 |